The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers.
published in: Arthritis & Rheumatology
date of publication: 2013-01-01
main subject: rheumatoid arthritis, seropositive rheumatoid arthritis, rituximab
Cites articles 29
- 2010-07-23
- 1980-02-01
Date
Title
Article - wd:Q45928777